Cargando…
The drug development pipeline for glioblastoma—A cross sectional assessment of the FDA Orphan Drug Product designation database
BACKGROUND: Glioblastoma (GBM) is the most common malignant brain tumour among adult patients and represents an almost universally fatal disease. Novel therapies for GBM are being developed under the orphan drug legislation and the knowledge on the molecular makeup of this disease has been increasin...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263276/ https://www.ncbi.nlm.nih.gov/pubmed/34234357 http://dx.doi.org/10.1371/journal.pone.0252924 |